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17O Relaxation Times in the Rat Brain at 16.4 Tesla
Hannes M. Wiesner,1,2 David Z. Balla,1 G. Shajan,1 Klaus Scheffler,1,3 Ka^mil Ugurbil,2y
Wei Chen,2 Ka^mil Uludag,4 and Rolf Pohmann1*y
Purpose: Measurement of the cerebral metabolic rate of oxygen
(CMRO2) by means of direct imaging of the
17O signal can be a
valuable tool in neuroscientific research. However, knowledge of
the longitudinal and transverse relaxation times of different brain
tissue types is required, which is difficult to obtain because of
the low sensitivity of natural abundance H2
17O measurements.
Methods: Using the improved sensitivity at a field strength of
16.4 Tesla, relaxation time measurements in the rat brain were
performed in vivo and postmortem with relatively high spatial
resolutions, using a chemical shift imaging sequence.
Results: In vivo relaxation times of rat brain were found to be
T1 ¼ 6.84 6 0.67 ms and T2* ¼ 1.77 6 0.04 ms. Postmortem
H2
17O relaxometry at enriched concentrations after inhalation of
17O2 showed similar T2* values for gray matter (1.87 6 0.04 ms)
and white matter, significantly longer than muscle (1.27 6 0.05
ms) and shorter than cerebrospinal fluid (2.30 6 0.16 ms).
Conclusion: Relaxation times of brain H2
17O were measured
for the first time in vivo in different types of tissues with high
spatial resolution. Because the relaxation times of H2
17O are
expected to be independent of field strength, our results
should help in optimizing the acquisition parameters for
experiments also at other MRI field strengths. Magn Reson
Med 000:000–000, 2015. VC 2015 Wiley Periodicals, Inc.
Key words: relaxation times; brain water distribution; natural
abundance oxygen-17; H2
17O; quadrupolar relaxation; X-Nuclei;
quantification; spectroscopic imaging; MRSI; ultra-high field
INTRODUCTION
In vivo imaging of oxygen metabolism, a key biological
parameter for characterizing the vital status of tissue, can
have a large impact in medicine and neuroscience. While
most established techniques used to measure the cerebral
metabolic rate of oxygen (CMRO2) have the limitations of
being either indirect (e.g., calibrated BOLD) (1,2) or invasive
[arteriovenous difference measurements (3–5) and positron
emission tomography (6)], MRI during catabolism of
enriched 17O2 to H2
17O can become a valuable alternative.
However, the NMR detection of 17O is challenging due to
its low gyromagnetic ratio (7), short transverse relaxation
times (8) and low natural abundance (9). The sensitivity of
17O NMR has been shown to increase almost quadratically
with field strength, supported by the field-independent
relaxation times of unbound H2
17O (8,10,11). Further
improvements can be realized by optimizing the acquisition
parameters based on the relaxation times (12,13).
The relaxation mechanisms of the 17O nucleus are sig-
nificantly different from those of protons due to the spin
of þ5/2 (7), generally being more intramolecular as a
result of quadrupolar interaction. Water as the exclusive
source of the in vivo NMR signal of 17O as triplet
(14–16) exhibits one peak in bulk water due to fast
hydrogen exchange and isotropic molecular motion (17).
At physiological conditions around neutral pH, the
relaxation of H2
17O is strongly influenced by chemical
exchange and by temperature (15). Because field-
dependent relaxation has been reported for bound water
(18), a regional determination of representative relaxation
times in complex in vivo tissue as a mixture of bound
and free water in the brain is important for applying
CMRO2 imaging through H2
17O NMR detection.
In this study, we determined the regional longitudinal
T1 and apparent transverse T2* relaxation times of H2
17O
at natural abundance and in enriched concentrations in
the rat head at 16.4T. Due to the high magnetic field and
optimized measurement parameters, local differences in
the relaxation times among different tissue types of rats
have been observed for the first time in vivo at relatively
high spatial resolutions. Additional phantom measure-
ments were performed to assess the changes of the relax-
ation times with the temperature, which is critical due
to the influence of viscosity and chemical exchange (19).
Previous relaxometric studies of H2
17O in rat brain
have not differentiated between different tissue types in
vivo. Finally, because pH, temperature, and concentra-
tions of salts affect the chemical exchange and molecular
motion, the linewidth of H2
17O is naturally autoregulated
in the brain within a narrow range. Therefore, the advan-
tages of ultra-high field MRI make it possible to obtain
the necessary signal sampling efficiency at sufficient spa-
tial resolutions and the observed field independence of
the H2
17O relaxation times ensures that these results can
easily be applied to studies at other field strengths.
METHODS
Instrumentation
Experiments were performed on a Bruker BioSpec
Avance III system (Bruker Biospin MRI GmbH, Ettlingen,
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Germany) based on a 16.4 Tesla (T) magnet (Magnex Sci-
entific, Abingdon, UK) with a 26-cm bore, equipped
with gradients with an inner diameter of 12 cm and a
maximum strength of 1 T/m within a rise time of 212 ms
(Resonance Research Inc., Billerica, MA). Custom-built
17O quadrature surface coils (diameter 1.5 cm; sensitive
detection depth  1 cm) (20) were tuned and matched
for every sample individually to the 17O Larmor-
frequency of 94.6 MHz. The signals from 0 and 90
channels were combined by a quadrature hybrid and
then amplified and digitized by a single-channel X-band
receiver. Mutual coupling between the two channels,
assessed by S21 measurements, was better than -20 dB.
For proton imaging, a separate 1H transmit and receive
butterfly coil was attached on top of the 17O coils.
Animal Preparation
All procedures and experiments were approved by the
local authorities and carried out by FELASA qualified
personnel in compliance with the guidelines of the Euro-
pean Community (EUVD 86/609/EEC) for the care and
use of laboratory animals. A total of 14 male Wistar rats
(Charles River Laboratories, Sulzfeld, Germany) were
used in this study. Animals were kept at a 12/12 h day/
night cycle with free access to nutrition and water.
In Vivo Measurements
Ten male Wistar rats were used for in vivo relaxometry
measurements (T1: n ¼ 5; mean body weight 513 6 71 g;
T2
*: n ¼ 5; mean body weight 529 6 30 g). Anesthesia
was induced in an induction chamber by 3–4% isoflur-
ane (ForeneVR , Abbott, Chicago, IL). During the prepara-
tion of the animal, anesthesia was maintained by
spontaneous inhalation of room air with 2% isoflurane
through an inhalation mask. A 22-gauge catheter (Veni-
systems AbbocathVR , Abbott Laboratories, UK) was
inserted into a lateral tail vein for intravenous infusion
of medetomidine anesthesia. The rat head was fixated in
a custom-built stereotaxic frame with the center of maxi-
mum sensitivity of the 17O-coil in Z-direction close to
the bregma of the rat skull. Lidocain spray (XylocainVR ,
AstraZeneca GmbH, Wedel, Germany) was applied topi-
cally before installation of the ear-bars. A subcutaneous
bolus of Flunixin-Meglumin (5 mg/kg; FinadyneVR , Essex
Pharma GmbH, M€unchen, Germany) was given as analge-
sic for the intravenous catheter and fixation. The transi-
tion to continuous medetomidine anesthesia (DomitorVR ,
Pfizer Inc., New York, NY) was initiated by intravenous
infusion at a rate of 0.1 mg/kg/h (dilution: 0.1 mg in 1-
mL saline solution with 16 IU/mL of heparin [heparin-
natrium 25000VR , ratiopharm GmbH, Ulm, Germany])
with successive discontinuation of isoflurane over 15–20
min (21). For the maintenance of anesthetic efficacy dur-
ing long experiments (22), the medetomidine infusion
rate was increased every 75 min by 50 mg/kg/h.
Breathing rate and exhaled respiration gases (Capstar-
100 End-tidal CO2 Analyzer, CWE Inc., Ardmore, PA) were
monitored and recorded (PowerLab & LabChart 5; ADIn-
struments, Australia). Rectally measured body temperature
was maintained at 36.8 6 0.5C by an electric heating pad
connected through a radiofrequency (RF) filter. After the
experiments, anesthesia was revoked using atipamezolhy-
drochlorid (AntisedanVR , Pfizer Inc., New York, NY).
Postmortem Experiments
Four male Wistar rats (mean body weight 380 6 131 g)
were initially anesthetized with 3–4% and kept at 2%
isoflurane during preparations. The animals were orally
intubated for mechanical ventilation and intravenously
catheterized for infusion of alpha-chloralose at 50 mg/kg/
h. Rats were positioned inside the magnet and were sub-
jected to a total approximately 90 min inhalation of 30%
O2 with a
17O2-enrichment of 70% (Nukem GmbH, Ger-
many) in N2O (one rat in N2) as part of a different study.
Two hours after inhalation, the animals were killed with
>5% isoflurane without changing their position within
the magnet. Acquisitions started 10 min after exitus with
the rat body allowed to equilibrate to ambient tempera-
ture in the magnet bore (21C at isocenter) (23).
MRI Experiments
Adjustments
The RF-power for a nominal 90 excitation at the 17O fre-
quency was calibrated globally for each individual sam-
ple by maximizing the signal of a “pulse-and-acquire”
sequence, using a 50 ms on-resonance block-pulse. For
anatomical imaging and shimming, a proton surface coil
was mounted on top of the 17O coil assembly, while in
some of the in vivo measurements a 1H resonator sur-
rounding the setup was used instead. First and second
order B0 shims were adjusted using FASTMAP (24) with
a 1-ms Gaussian pulse. Proton images were acquired at
high in-plane resolutions with equal slice thickness as
the corresponding H2
17O images.
For in vivo H2
17O imaging, a three-dimensional (3D)
chemical shift imaging (CSI) sequence using weighted
averaging of the k-space was applied (25,26). To obtain
sufficient signal despite the short transverse relaxation
time, the acquisition delay between the middle of the
excitation pulse and the start of the acquisition was
minimized to 484 ms. Because a nonselective excitation
pulse was used, the sensitive region in the field of view
(FOV) of the 3D CSI sequence with free induction decay
(FID) detection was determined by the profile of the sur-
face coil. The raw data was Fourier transformed along
the three spatial dimensions, resulting in localized FIDs,
which were used to estimate T2* times. Subsequent Fou-
rier transformation of the time domain resulted in local-
ized spectra. The amplitudes of the phased water peaks
were used to construct the final H2
17O images.
Phantom measurements
Reference relaxation time measurements on pure water
with 20 mL of a 10%-enriched H2
17O water phantom
(Nukem GmbH, Germany) in a glass tube were performed
at room temperature.
T1 and T2* were measured as described below. A
region of interest (ROI) in the center of the phantom was
selected to avoid potential effects of superficial heating
caused by the specific absorption rate (SAR) of RF-power
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and to attenuate susceptibility effects in peripheral
regions of the phantom.
T1 Relaxometry
Inversion recovery images were acquired with 20 inver-
sion delays ranging from 0.5 ms to 45 ms in logarithmi-
cally increasing steps, using an adiabatic hyperbolic
secant pulse (duration 0.5 ms, bandwidth 10 kHz) for
inversion. Imaging parameters were: FOV 30  15.71  27
mm3; matrix size 21  11  9 (nominal voxel volume
6.12 mL); relaxation delay 45 ms (TR  5 T1); 50 ms pulse
for excitation with a nominal flip angle of 90. A total of
10,240 FIDs for each inversion step were acquired within
7–15 min (depending on the inversion time) with a maxi-
mum of 41 averages in the center of k-space. Spectro-
scopic data of 1250 points per FID was recorded within
10 ms with a bandwidth of 125 kHz (1321 ppm).
T1 was determined by a mono-exponential fit of the
intensity of selected voxels, using standard nonlinear
least-squares algorithms (Curve Fitting Toolbox,
MATLABVR , The Mathworks Inc., Natick, MA). The sig-
nal intensities for short inversion times were inverted
while measurements within one standard deviation
around the noise level were excluded before fitting.
The different tissue types were classified based on the
proton images with reference to a rat brain atlas (27). At
least two voxels between different tissue regions were not
included along the outer boundary of ROIs to avoid par-
tial volume contaminations due to the large voxel sizes in
the H2
17O measurements. The T1-measurement covered a
region of 0.9 to 1.5 cm in Z-direction (depending on the
size of the rat), and thus most of each rat brain. Only vox-
els inside the brain with a sufficient spectral signal-to-
noise ratio (SNR) > 12 were fitted, which resulted in a
ratio of 56% brain versus 44% muscle voxels on average.
T2* Relaxometry In Vivo
For T2* quantification, a short TR of 4.9 ms and a flip
angle of 67.5, close to the expected Ernst angle for the
rat brain (FA ¼ 64 for T1 at 17.6T) (28) was used to sam-
ple 3D CSI with a FOV of 27.5  12.5  22 mm3 and a
39  17  15 matrix (nominal voxel volume 0.76 mL).
Three million FIDs (375 spectral points, bandwidth 100
kHz, 2811 averages in the center of k-space) were
acquired within 4 h and 6 min from each rat.
The real part of the Fourier-transformed FID was
frequency-corrected by adjusting the phase in the time-
domain and fitted against a monoexponential decay.
Voxel-wise estimated relaxation times were averaged
over manually selected ROIs for each tissue type. Extrap-
olating the FIDs to zero excitation and acquisition delay
resulted in T1-weighted images, after normalizing the
intensity by correcting for B1 inhomogeneity as deter-
mined in a phantom (29).
T2* Relaxometry Postmortem
For high-resolution anatomical images and T2* quantifi-
cation, a CSI-sequence without k-space weighting with a
TR of 12 ms and a flip angle of 90 was used. To avoid
RF-induced heating, the excitation pulse length was
increased to 400 ms to compensate for the lack of the
cooling effect of blood circulation.
A FOV of 27.5  12.5  25 mm3 was sampled with a
matrix of 41  19  25 voxels (voxel volume 0.44 mL).
Approximately 2.5 million FIDs with 1000 points each
and a spectral bandwidth of 100 kHz were acquired
within 8 h and 18 min. Postprocessing for T2* was then
performed as in vivo.
Relaxation times are given as mean value 6 standard
deviation over all voxels of the selected region, with the
nominal volume of the ROI added in brackets, if applicable.
RESULTS
Phantom Measurements
Phantom measurements on the 10%-enriched H2
17O
water sample resulted in a T1 value of 6.24 6 0.37 ms
over the sensitive region of the surface coil, indicating
stable T1-quantification and an efficient inversion over
the entire FOV. In the same phantom, a T2* of 2.24 6
0.09 ms was found.
In Vivo Relaxation Times T1
T1-values for all rats are shown in Table 1. The T1 of
brain tissue (gray and white matter) was 6.84 6 0.67 ms
and significantly higher than that of muscle (5.67 6 1.12
ms). Muscle tissue could be clearly differentiated from
brain in image intensity (Fig. 1b) and relaxation times
(Fig. 1c). No significant intracerebral contrast was
observed at this resolution. A repeated measurement in
the same rat in a different session demonstrated highly
reproducible T1-values (Table 1; rat 5).
In Vivo and Postmortem Relaxation Times T2*
In the high-resolution H2
17O images, intracortical struc-
tures were consistently visible due to the decreased
image intensity of white matter (i.e., corpus callosum
and optic radiation) against cortical gray matter in all
animals, both in vivo and postmortem. T2* of brain tis-
sue had a mean value of 1.77 6 0.04 ms and did not
vary significantly between white and gray matter
(Fig. 2c; Table 2a), while being significantly increased in
cerebrospinal fluid (CSF), e.g., in the ventricles (in vivo:
2.21 6 0.20 ms; postmortem: 2.30 6 0.16 ms, Table 2). A
T2
* of 4 ms was measured in the eyes, too small in vol-
ume for quantitative evaluation. No significant deviation
from a single exponential relaxation behavior was
Table 1
In Vivo T1 Relaxation Times in ms of Natural Abundance H2
17O
measured in the Rat Head
In vivo T1 Muscle tissue Brain tissue
rat 1 (583 g) 5.25 6 1.02 (324 mL)* 6.34 6 0.67 (477 mL)*
rat 2 (415 g) 6.47 6 1.15 (459 mL) 6.84 6 0.62 (441 mL)
rat 3 (483 g) 5.86 6 1.10 (275 mL)* 7.64 6 0.52 (282 mL)*
rat 4 (580 g) 5.22 6 0.84 (214 mL)* 6.58 6 0.39 (398 mL)*
rat 5 (504 g) #1 5.45 6 0.71 (312 mL)* 6.79 6 0.40 (398 mL)*
rat 5 (504 g) #2 5.74 6 0.70 (312 mL)* 6.83 6 0.45 (398 mL)*
Pop. Mean [ms] 5.67 6 1.12* 6.84 6 0.67*
*P < 0.05; significant population difference between muscle and
brain tissue (paired t-test).
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apparent in the signal time course of the localized FIDs
as used for the T2* estimations (Fig. 3a). Extrapolation to
TE ¼ 0 yielded combined spin density- and T1-weighted
images (Fig. 3c), showing highest signal intensity in
muscle tissue and lowest in CSF and ventricles, confirm-
ing the lower T1 in muscle than in brain (Fig. 1c).
Rats undergoing 17O2-inhalations which were used for
the postmortem T2* measurements showed a global
increase of the image intensity by a factor of 4 to 5 com-
pared with the natural abundance H2
17O signal, due to sig-
nificant metabolic conversion of 17O2 to H2
17O. No intra-
cortical difference from metabolic rates (e.g., between
white and gray matter) was detectable, due to the long
duration of anatomical acquisition (i.e., diffusion of locally
elevated H2
17O concentration in equilibrium due to
exhaustion of concentration gradients). Postmortem T2*
values in muscle, GM and WM tissue were slightly
increased compared with in vivo data, whereas the differ-
ence between brain tissue and CSF remained similar
(Table 2b). This was accompanied by a generally decreased
image contrast in the postmortem measurements, espe-
cially in regions with high water content (Fig. 4).
DISCUSSION
In this study, we have taken advantage of the increased
signal at ultra-high magnetic field to quantify H2
17O
relaxation times in the rat brain in vivo, for the first time
differentiating different tissue types with relatively high
spatial resolution. The results of this study should be
beneficial to design future experiments, but also to
assess the results of previous quantitative examinations.
While a spectroscopic technique was used in all acquisi-
tions to reach high sensitivity for the rats with and with-
out 17O2 inhalation, no metabolite peaks except the
water signal were observable in our spectra (30–34)
because of the limited excitation bandwidth in relation
to the large range of chemical shifts with molecules con-
taining 17O.
Phantom Studies
Our phantom measurements are in relative agreement
with results from previous nonlocalized measurements
which reported values of T1 around 6–8 ms for enriched
pure water (35) at physiological temperatures. Tempera-
ture controlled T2* measurements using continuous
wave NMR reported T2* up to 4 ms at enriched H2
17O
concentrations (36,37) in contrast to our significantly
lower values, which could be a result of the higher
achievable B0 field-homogeneity in nonlocalized NMR
spectroscopy, of better temperature control in the nonlo-
calized measurements in NMR spectrometers and higher
purity from paramagnetic ions of the glassware being
FIG. 1. Longitudinal relaxation time T1. a: Proton FLASH image of a coronal slice in the rat head in vivo. b: Signal intensity of the H2
17O
spectral peak at natural abundance concentration of the same slice with delineations of forebrain (yellow) and surrounding muscle (red).
c: Corresponding slice of H2
17O in vivo T1 relaxation times with clear differences between brain and muscle tissue. A 5-mm scale bar
(green) is shown for the colocalized slices.
Table 2
In Vivo and Postmortem T2
* Relaxation Times in ms of H2
17O measured in the Rat Head
a) In vivo T2
* (natural abundance)
Muscle tissue WM GM CSF
rat A (567 g) 1.03 6 0.18 (309 mL) 1.86 6 0.15 (24 mL) 1.83 6 0.13 (111 mL) 2.56 6 0.23 (38 mL)
rat B (499 g) 1.07 6 0.18 (296 mL) 1.78 6 0.09 (29 mL) 1.75 6 0.08 (126 mL) 2.19 6 0.12 (27 mL)
rat C (503 g) 1.08 6 0.17 (301 mL) 1.75 6 0.11 (25 mL) 1.73 6 0.10 (128 mL) 2.13 6 0.16 (28 mL)
rat D (526 g) 1.15 6 0.16 (361 mL) 1.71 6 0.10 (20 mL) 1.77 6 0.08 (148 mL) 2.14 6 0.11 (27 mL)
rat E (552 g) 1.27 6 0.15 (315 mL) 1.77 6 0.08 (14 mL) 1.76 6 0.15 (100 mL) 2.05 6 0.11 (10 mL)
Pop. Mean [ms] 1.12 6 0.09* 1.77 6 0.06 1.77 6 0.04 2.21 6 0.20*
b) Postmortem T2
* (enriched 4–5 times of natural abundance)
rat F (250 g) 1.30 6 0.21 (232 mL) 1.81 6 0.17 (33 mL) 1.83 6 0.15 (199 mL) 2.27 6 0.35 (14 mL)
rat G (430 g) 1.28 6 0.16 (239 mL) 1.84 6 0.21 (25 mL) 1.85 6 0.17 (182 mL) 2.26 6 0.39 (9 mL)
rat H (540 g) 1.29 6 0.25 (276 mL) 1.91 6 0.33 (24 mL) 1.92 6 0.21 (102 mL) 2.14 6 0.44 (8 mL)
rat I (300 g) 1.20 6 0.16 (207 mL) 1.87 6 0.16 (22 mL) 1.89 6 0.12 (175 mL) 2.53 6 0.35 (25 mL)
Pop. Mean [ms] 1.27 6 0.05* 1.86 6 0.04 1.87 6 0.04 2.30 6 0.16*
*P < 0.01 significant population difference between muscle/CSF and brain tissue (paired t-test).
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used (35). Furthermore, a fair amount of one-
dimensional experiments in the 1970s accumulated in
vitro estimations of muscle tissue T1 and T2 (37–39). In
contrast to proton MRI, T2* contrast changes close to air-
sample borders were not observed in any images nor
with varying voxel sizes as the frequency of H2
17O at
FIG. 2. Apparent in vivo transverse relaxation time T2*. a: Coronal FLASH proton image. b: CSI anatomical contrast of rat tissues in
image intensity of H2
17O with intra-cortical differentiations of white matter and ventricles. c: T2* estimates of H2
17O with pronounced dif-
ferentiation between brain parenchyma (gray matter, white matter) and cerebrospinal fluid in the ventricles.
FIG. 3. a: Semi-logarithmic plot of the MR-signal (real part) averaged over ROIs of one rat from the in vivo measurements with fitted T2*
relaxation curves for four tissue types. Free induction decays of different tissue types show high linearity without pronounced modula-
tions. b: Reconstructed image of muscle and brain tissue based on the spectral peak of H2
17O. c: T1-weighted image generated by
extrapolation of the FIDs (see text) to an acquisition delay of t ¼ 0 for the same coronal slice as shown in b).
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16.4 Tesla used in this study translates to a larmor fre-
quency of 2.2T for protons. In addition, peak intensity
changed by less than 15% comparing unlocalized spectra
with and without B0-shimming, (i.e., with a smaller
change in T2*).
Tissue Specific Relaxation and Anatomical Contrast
The differences between muscle and brain tissue H2
17O
relaxation times have similar proportions as those known
from proton measurements (40–42) and cannot be
explained from temperature difference alone. However,
intracortical differences are much less pronounced than
for proton MRI due to the limited influence of the inter-
molecular environment on the field-independent relaxa-
tion of H2
17O (43). The lack of differentiable T2*
relaxation times between gray and white matter and the
clear separation by low intensity of white matter struc-
tures indicate a difference in either T1 or in H2
17O con-
centration (Fig. 3c). The latter could be due to the
variations in water content of more than 15% between
gray and white matter as found in the human brain (44)
and could affect natural abundance H2
17O calibration
(45).
The higher intersubject variability of the T1 measure-
ments compared with the T2* data (Table 1 versus 2) is
mainly due the lower sensitivity of the inversion recov-
ery sequence compared with the simple FID acquisition
used to determine T2*. In part, choosing larger voxels for
the T1 measurements compensated for this. However, the
low sensitivity of H2
17O in general requires multiple rep-
etitions for averaging the signal both in T1 and T2* meas-
urements, which is possible due to the generally short T1
in contrast to more slowly relaxing nuclei like protons.
Most previous investigations on oxygen consumption
were limited in localization because of the low sensitiv-
ity of the 17O nucleus, thus neglecting potential contri-
butions from nonbrain tissue. In animal studies using
surface coils for detection, the signal from muscles could
cause significant confound, owing to the property of
small coils to overemphasize superficial (i.e., proximal)
anatomical structures. However, our results indicate that
the low T2* values in muscle tissues presented here
assure that the signal contribution from this tissue type
will play a less dominating role when sufficiently long
TE is used.
While the still relatively large voxels sizes may lead to
residual partial volume effects, further increasing the
spatial resolution, which is constricted by the low SNR
of the measurements, will be challenging. In our experi-
ments, we have chosen a CSI sequence because of its
high SNR efficiency and its short acquisition delay. The
necessary SNR gain for improving the resolution might
be possible by further reducing the signal loss due to
transverse relaxation by using imaging sequences with
ultrashort or even zero TE.
Comparison of In Vivo and Postmortem
Differences between in vivo and postmortem relaxation
times reflect well known effects from previous studies
(e.g., due to cell rupture, increased diffusion between
intra- and extracellular space and differences in tempera-
ture) (23,46). Temperature changes due to the rapid suc-
cession of RF-pulses can distort the resulting relaxation
times especially in the postmortem measurements, where
the body temperature is lower and no perfusion dissi-
pates the heat. While SAR was reduced in these meas-
urements by increasing the pulse duration, regions close
to the coil, especially in the skeletal muscles, may heat
up, explaining the slightly higher T2* in those regions.
In the ex vivo measurements, it was possible to reach
FIG. 4. Apparent postmortem transverse relaxation time T2*. a: Postmortem images with increased H2
17O concentration due to meta-
bolic enrichment after inhalation of 17O2 gas. Olfactory bulb, forebrain, thalamus and cortex are shown with clear contrast between
white matter (corpus callosum) and ventricles. b: T2* map of the same slices as in a) exhibiting slightly increased relaxation times in
cortical fluids of the ventricles.
FIG. 5. Literature comparison of T2* relaxation times at different
B0 field strength of in vivo brain tissue. Span of error bar equals
standard deviation, if available.
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even higher spatial resolutions due to the H2
17O enrich-
ment and the long measurement times.
17O Relaxation Times across Field Strength
In contrast to proton MRI, the longitudinal and transverse
relaxation times of H2
17O are expected to be independent
of field strength. Figure 5 shows an overview of previ-
ously published T2*-values at different field strengths
(8,47–50), including the results from the current study.
All brain tissue T2* values are remarkably close around
1.8 ms, because the tissue is maintained in an auto-
regulatory regime of temperature and pH, some of the
most dominant factors for transverse H2
17O relaxation.
This data is consistent with the assumption of field-
independent relaxation times, albeit a slight tendency to
shorter T2* (Fig. 5) might be visible in muscle tissue.
Differences to previous studies might be due to differ-
ences in temperature, which may result from convection
effects or the different temperature controlling procedures.
They can also be caused by RF-heating in in vivo experi-
ments, because the short T1 and T2* and the necessity of
rapid averaging increase SAR. For 17O experiments at
high fields, SAR monitoring and reduction is critical
especially with humans. Thus, in the postmortem study
we used longer RF excitation pulses to avoid excessive
heating at the expense of signal loss due to relaxation dur-
ing the pulse. Further discrepancies between the current
study and previous experiments may be due to differen-
ces in the sampled tissue, because most previous in vivo
data were acquired with limited spatial localization and
might represent a different mixture of tissue types.
CONCLUSIONS
The use of ultrahigh field strength made it possible to
determine tissue specific 17O relaxation parameters.
These might be used for sequence optimization (13,51)
and analysis of data acquired using short TR during
inhalation of enriched 17O2 gas for the determination of
CMRO2. Due to the apparent field independence of the
17O relaxation times, the results can easily be transferred
to lower field strengths, as long as tissue and tempera-
ture differences are taken into account.
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